VESIcare Drug Interactions
Currently displaying 374 drugs known to have a moderate interaction with VESIcare (solifenacin).
Moderate interactions with VESIcare (solifenacin)
Note: Showing generic names only.
A
- abametapir topical
- abarelix
- abiraterone
- abobotulinumtoxinA
- acetylcholine ophthalmic
- aclidinium
- acrivastine
- adenosine
- albuterol
- alfentanil
- alfuzosin
- allopurinol
- amantadine
- ambenonium
- aminoglutethimide
- amitriptyline
- amobarbital
- amoxapine
- apalutamide
- apomorphine
- aprepitant
- arbutamine
- arformoterol
- aripiprazole
- asciminib
- asenapine
- astemizole
- atomoxetine
- atropine
- avacopan
- azatadine
- azithromycin
B
- belladonna
- belzutifan
- benztropine
- berotralstat
- bethanechol
- bexarotene
- bicalutamide
- biperiden
- bisacodyl
- bitolterol
- bosentan
- brexpiprazole
- brigatinib
- brompheniramine
- buprenorphine
- butabarbital
- butalbital
- butorphanol
C
- capivasertib
- carbachol ophthalmic
- carbamazepine
- carbinoxamine
- cariprazine
- casanthranol
- cascara sagrada
- castor oil
- cenobamate
- cevimeline
- chloramphenicol
- chlorcyclizine
- chlorpheniramine
- chlorpromazine
- cilostazol
- cimetidine
- ciprofloxacin
- clemastine
- clidinium
- clofazimine
- clomipramine
- clotrimazole
- codeine
- cyclizine
- cyclobenzaprine
- cyclosporine
- cyproheptadine
D
- dabrafenib
- danazol
- darifenacin
- darolutamide
- darunavir
- dasatinib
- daunorubicin
- daunorubicin liposomal
- daxibotulinumtoxinA
- deferasirox
- degarelix
- demecarium bromide ophthalmic
- desipramine
- deutetrabenazine
- dexamethasone
- dexbrompheniramine
- dexchlorpheniramine
- dezocine
- dicyclomine
- diltiazem
- dimenhydrinate
- diphenhydramine
- donepezil
- doxepin
- doxepin topical
- doxorubicin
- doxorubicin liposomal
- doxylamine
- duvelisib
E
- echinacea
- echothiophate iodide ophthalmic
- edrophonium
- elafibranor
- elagolix
- eluxadoline
- encorafenib
- entrectinib
- enzalutamide
- epirubicin
- eribulin
- etravirine
- ezogabine
F
- famotidine
- fedratinib
- felbamate
- fentanyl
- fesoterodine
- flavoxate
- flecainide
- fluconazole
- fluoxetine
- fluphenazine
- flutamide
- fluvoxamine
- formoterol
- fosaprepitant
- foscarnet
- fosphenytoin
- fostamatinib
- fostemsavir
G
- galantamine
- gemifloxacin
- gepirone
- gilteritinib
- givinostat
- glasdegib
- glycerin
- glycopyrrolate
- glycopyrronium topical
- goserelin
- granisetron
- griseofulvin
- guanidine
H
I
- idarubicin
- imatinib
- imipramine
- incobotulinumtoxinA
- indacaterol
- inotuzumab ozogamicin
- ipratropium
- isavuconazonium
- isocarboxazid
- isoetharine
- isoflurophate ophthalmic
- isoniazid
- isoproterenol
- ivacaftor
L
- lactitol
- lactulose
- lapatinib
- larotrectinib
- lenacapavir
- lenvatinib
- letermovir
- letibotulinumtoxinA
- leuprolide
- levalbuterol
- levodopa
- levofloxacin
- levorphanol
- lisdexamfetamine
- lithium
- lofexidine
- lomefloxacin
- lomitapide
- lonapegsomatropin
- loperamide
- lorlatinib
- loxapine
- lumateperone
- lurasidone
M
- macimorelin
- magnesium citrate
- magnesium hydroxide
- maprotiline
- mavacamten
- mavorixafor
- meclizine
- mefloquine
- mepenzolate
- meperidine
- mephobarbital
- metaproterenol
- methdilazine
- methotrimeprazine
- methscopolamine
- metoclopramide
- metronidazole
- miconazole
- midostaurin
- mineral oil
- mirabegron
- mirtazapine
- mitapivat
- mitotane
- molindone
- morphine
- morphine liposomal
N
- nafcillin
- nalbuphine
- neostigmine
- nevirapine
- nifedipine
- nilutamide
- nirogacestat
- norfloxacin
- nortriptyline
O
- ofloxacin
- olanzapine
- oliceridine
- olodaterol
- olutasidenib
- omaveloxolone
- onabotulinumtoxinA
- ondansetron
- opium
- orphenadrine
- osilodrostat
- oxaliplatin
- oxcarbazepine
- oxybutynin
- oxycodone
- oxymorphone
- oxytocin
P
- palbociclib
- paliperidone
- palonosetron
- pazopanib
- pentamidine
- pentazocine
- pentobarbital
- perflutren
- perphenazine
- pexidartinib
- phenelzine
- phenindamine
- phenobarbital
- phenolphthalein
- phenylbutazone
- phenytoin
- physostigmine
- physostigmine ophthalmic
- pilocarpine
- pilocarpine ophthalmic
- pimavanserin
- pirbuterol
- pirtobrutinib
- polyethylene glycol 3350
- polyethylene glycol 3350 with electrolytes
- prabotulinumtoxinA
- pralsetinib
- pramlintide
- primaquine
- primidone
- probucol
- prochlorperazine
- procyclidine
- promazine
- promethazine
- propafenone
- propantheline
- propiomazine
- propofol
- propoxyphene
- protriptyline
- prucalopride
- pyridostigmine
- pyrilamine
Q
R
- ranolazine
- relugolix
- remifentanil
- repotrectinib
- revefenacin
- rifabutin
- rifampin
- rifapentine
- rilpivirine
- rimabotulinumtoxinB
- risperidone
- ritlecitinib
- ritodrine
- rivastigmine
- romidepsin
- rucaparib
S
- salmeterol
- scopolamine
- secobarbital
- senna
- sertraline
- sevoflurane
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sorafenib
- sotorasib
- st. john's wort
- stiripentol
- sufentanil
- sulfinpyrazone
- sunitinib
- suvorexant
T
- tacrine
- tacrolimus
- tamoxifen
- tapentadol
- tazemetostat
- tebentafusp
- tecovirimat
- telavancin
- telotristat
- terbutaline
- terfenadine
- tetrabenazine
- thalidomide
- thiethylperazine
- thiothixene
- ticagrelor
- tiotropium
- tirzepatide
- tizanidine
- tolterodine
- tovorafenib
- tramadol
- tranylcypromine
- trazodone
- triclabendazole
- trifluoperazine
- triflupromazine
- trihexyphenidyl
- trimeprazine
- trimipramine
- tripelennamine
- triprolidine
- triptorelin
- trofinetide
- troglitazone
- trospium
U
V
Z
VESIcare disease interactions
There are 7 disease interactions with VESIcare (solifenacin) which include:
- GI motility
- kidney impairment
- liver impairment
- narrow-angle glaucoma
- urinary obstruction
- CNS
- QT prolongation
More about VESIcare (solifenacin)
- VESIcare consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (141)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: urinary antispasmodics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.